Literature DB >> 1972488

Preliminary report: role of peptide YY in defence against diarrhoea.

R J Playford1, J Domin, J Beacham, K B Parmar, K Tatemoto, S R Bloom, J Calam.   

Abstract

To investigate whether peptide YY (PYY) has a role in minimising fluid loss during diarrhoea, its effect on hypersecretion induced by vasoactive intestinal peptide (VIP) was studied in seven subjects with ileostomies. An isotonic electrolyte solution containing polyethylene glycol 4000 was infused directly into the duodenum and the effluent was collected for 40 min (baseline), then VIP was infused intravenously at 5 pmol.kg-1.min-1 for 500 min. PYY was infused intravenously at low doses (0.4 and 0.2 pmol.kg-1.min-1) for 100 min each during the continuous VIP infusion. Small-intestinal secretion was assessed by effluent weight and by polyethylene glycol dilution, which gave similar results. Plateau ileal output was 501 (SEM 33) ml/h during VIP infusion. PYY caused significant falls in secretion--to 404 (48) ml/h for the lower dose and to 323 (75) ml/h for the higher. It also prolonged small-bowel transit. These findings suggest that PYY is a natural inhibitor of diarrhoea and that its therapeutic potential merits investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972488     DOI: 10.1016/0140-6736(90)91378-n

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Peptide YY and electrolyte homeostasis.

Authors:  R J Playford; C E Macdonald
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

Review 2.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

3.  Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.

Authors:  Helen M Cox; Iain R Tough
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

4.  The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.

Authors:  N D Holliday; H M Cox
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 5.  Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea.

Authors:  Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-17       Impact factor: 11.382

6.  Do elevated plasma vasoactive intestinal polypeptide (VIP) levels cause small intestinal motor disturbances in humans?

Authors:  Jutta Keller; Jan C Mueller-Wolf; Keihan Ahmadi-Simab; Christiane Fibbe; Ulrich Rosien; Peter Layer
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

7.  The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.

Authors:  Niall P Hyland; Helen M Cox
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

8.  Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.

Authors:  Helen M Cox; Iain R Tough; Anne-Marie Woolston; Lei Zhang; Amy D Nguyen; Amanda Sainsbury; Herbert Herzog
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

9.  Peptide YY enhances NaCl and water absorption in the rat colon in vivo.

Authors:  M Okuno; T Nakanishi; Y Shinomura; T Kiyohara; H Ishikawa; S Tarui
Journal:  Experientia       Date:  1992-01-15

10.  Functional characterization of receptors with affinity for PYY, NPY, [Leu31,Pro34]NPY and PP in a human colonic epithelial cell line.

Authors:  H M Cox; I R Tough
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.